Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02403466 · ClinicalTrials.gov registry record · NA
IIPE-PRIS Accelerating Safe Signouts
A NA study, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 875
- Enrollment target
NCT02403466: Completed NA study, sponsored by Boston Children's Hospital.
NCT02403466 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 875 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02403466, a NA study, has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 875 participants
- Enrollment target
Study Summary
Because communication and handoff failures are a root cause of two-thirds of "sentinel events"- serious, often fatal preventable adverse events in hospitals improving handoffs has been identified by AHRQ and the Joint Commission as a priority in nationwide efforts to improve patient safety. Comparative Effectiveness Research on handoff tools and processes has identified specific strategies to improve handoffs and reduce medical errors: 1) team training; 2) verbal mnemonics; and 3) use of written/computerized tools to supplement verbal sign-outs. To accelerate residents' use of CER-based handoff practices and improve patient safety, the investigators are implementing the three inventions above as a Resident Handoff Bundle (RHB) in eight pediatric hospitals in the United States and Canada.
Interventions
- BEHAVIORAL Resident Handoff Bundle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 875 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT02403466 record still lists
NCT02403466 is an interventional study that assigns participants to a tested intervention. The registered 875 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).
The record links to 0 conditions, and to 1 intervention - of which Resident Handoff Bundle is the first listed.
NCT02403466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02403466 about?
NCT02403466 is a clinical study titled "IIPE-PRIS Accelerating Safe Signouts". Because communication and handoff failures are a root cause of two-thirds of "sentinel events"- serious, often fatal preventable adverse events in hospitals improving handoffs has been identified by AHRQ and the Joint Commission as a priority in nationwide efforts to improve patient safety. Comparat...
What is the current status of trial NCT02403466?
This trial is currently completed. It is a NA study. The enrollment target is 875 participants. The study started on 2010-09. Estimated completion is 2013-08.
What interventions are being tested in trial NCT02403466?
The interventions under investigation include: Resident Handoff Bundle (BEHAVIORAL).
Who is sponsoring clinical trial NCT02403466?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02403466's enrollment target sits among peer trials
875 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07076199 · 877 participants · Phase 3
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes
- NCT06627647 · 878 participants · Phase 3
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-squamous NSCLC
- NCT05174286 · 880 participants · NA
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
- NCT05454280 · 880 participants · Phase 3
Post-Discharge Risk-Based Management in Patients Undergoing High-Risk Elective Major Cancer Operations (PRS II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia